Log in Register
Menu

T47D/S5 Cell Line

Invented by Dr Anne Lykkesfeldt at Danish Cancer Society

Info

Catalogue Number 152111
Antigen/Gene or Protein Targets Oestrogen receptor
Parental Line T47D
Host Human
Tissue Breast
Disease Keywords Breast cancer
Model Tumour line
Relevance The T47D/S5 Cell line is the control for the fulvestrant resistant T47D/182R-1 and T47D/182R-2 cell lines. Antiestrogen resistance is a major problem in breast cancer treatment. Therefore, the search for new therapeutic targets and biomarkers for antiestrogen resistance is crucial.
Production Details T47D/S5 cells grows continuously in presence of 5% fetal calf serum.
Research Area Cancer, Drug Discovery & Development
Recommended Growing Conditions Phenol red free RPMI 1640 + 5% FCS + glutamax + 8µg Insulin/ml
Notes T47DS5 cells express ER alpha and progesterone receptor.

Passage 155 (AL3043, AL3044)
Cellosaurus ID CVCL_1D46

References: 4 entries

Larsen et al. 2015. PLoS One. 10(2):e0118346. PMID: 25706943.

Larsen et al. 2015. BMC Cancer. 15:239. PMID: 25885472.

Thrane et al. 2014. Oncogene. :. PMID: 25362855.

Kirkegaard et al. 2014. Cancer Lett. 344(1):90-100. PMID: 24513268.


Add a reference

References: 4 entries

Larsen et al. 2015. PLoS One. 10(2):e0118346. PMID: 25706943.

Larsen et al. 2015. BMC Cancer. 15:239. PMID: 25885472.

Thrane et al. 2014. Oncogene. :. PMID: 25362855.

Kirkegaard et al. 2014. Cancer Lett. 344(1):90-100. PMID: 24513268.


Add a reference

References: 4 entries

Larsen et al. 2015. PLoS One. 10(2):e0118346. PMID: 25706943.

Larsen et al. 2015. BMC Cancer. 15:239. PMID: 25885472.

Thrane et al. 2014. Oncogene. :. PMID: 25362855.

Kirkegaard et al. 2014. Cancer Lett. 344(1):90-100. PMID: 24513268.


Add a reference


This reagent does not have any reviews at the moment.